Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Sandovici

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Frontiers in Nuclear Medicine|March 25, 2025
18F-FDG-PET/CT for polymyalgia rheumatica: agreement and diagnostic accuracy of routine PET scan report vs. standardized PMR PET scoresKornelis S M van der Geest, Rob G J Grootelaar, Karin Bouwman, et al.
Annals of the Rheumatic Diseases|August 12, 2022
Expression of interleukin-6 in synovial tissue of patients with polymyalgia rheumaticaWilliam F Jiemy, Anqi Zhang, Annemieke M H Boots, et al.
Clinical & Translational Immunology|September 5, 2020
Distinct macrophage phenotypes skewed by local granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritisWilliam F Jiemy, Yannick van Sleen, Kornelis Sm van der Geest, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 14, 2023
Indication of Activated Senescence Pathways in the Temporal Arteries of Patients With Giant Cell ArteritisWilliam F Jiemy, Yannick van Sleen, Jacoba C Graver, et al.
Rheumatology (Oxford, England)|March 14, 2025
Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritisShuang Xu, William Jiemy, Yannick van Sleen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2021
A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 AxisYannick van Sleen, William F Jiemy, Sarah Pringle, et al.
Rheumatology (Oxford, England)|June 12, 2021
Comparison and validation of FDG-PET/CT scores for polymyalgia rheumaticaKornelis S M van der Geest, Yannick van Sleen, Pieter Nienhuis, et al.
Rheumatology (Oxford, England)|April 23, 2022
Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8+ T cells in giant cell arteritisRosanne D Reitsema, Kornelis S M van der Geest, Maria Sandovici, et al.
Rheumatology (Oxford, England)|August 12, 2025
Crosstalk between macrophages and fibroblasts contributes to inflammation and damage in giant cell arteritisShuang Xu, William F Jiemy, Anqi Zhang, et al.
Arthritis Care & Research|April 30, 2024
Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell ArteritisShuang Xu, William F Jiemy, Annemieke M H Boots, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Nuclear Medicine|March 25, 2025
18F-FDG-PET/CT for polymyalgia rheumatica: agreement and diagnostic accuracy of routine PET scan report vs. standardized PMR PET scoresKornelis S M van der Geest, Rob G J Grootelaar, Karin Bouwman, et al.
Annals of the Rheumatic Diseases|August 12, 2022
Expression of interleukin-6 in synovial tissue of patients with polymyalgia rheumaticaWilliam F Jiemy, Anqi Zhang, Annemieke M H Boots, et al.
Clinical & Translational Immunology|September 5, 2020
Distinct macrophage phenotypes skewed by local granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritisWilliam F Jiemy, Yannick van Sleen, Kornelis Sm van der Geest, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 14, 2023
Indication of Activated Senescence Pathways in the Temporal Arteries of Patients With Giant Cell ArteritisWilliam F Jiemy, Yannick van Sleen, Jacoba C Graver, et al.
Rheumatology (Oxford, England)|March 14, 2025
Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritisShuang Xu, William Jiemy, Yannick van Sleen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2021
A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL-40/Interleukin-13 Receptor α2 AxisYannick van Sleen, William F Jiemy, Sarah Pringle, et al.
Rheumatology (Oxford, England)|June 12, 2021
Comparison and validation of FDG-PET/CT scores for polymyalgia rheumaticaKornelis S M van der Geest, Yannick van Sleen, Pieter Nienhuis, et al.
Rheumatology (Oxford, England)|April 23, 2022
Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8+ T cells in giant cell arteritisRosanne D Reitsema, Kornelis S M van der Geest, Maria Sandovici, et al.
Rheumatology (Oxford, England)|August 12, 2025
Crosstalk between macrophages and fibroblasts contributes to inflammation and damage in giant cell arteritisShuang Xu, William F Jiemy, Anqi Zhang, et al.
Arthritis Care & Research|April 30, 2024
Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell ArteritisShuang Xu, William F Jiemy, Annemieke M H Boots, et al.
Pageof 8